De novo mutations in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)

Kathrin N Karle1, Saskia Biskup, Rebecca Schüle

  • 1From the Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research and Department of Neurology (K.N.K., S.B., R.S., K.J.S., R.K., L.S.), Institute of Medical Genetics and Applied Genomics (P.B.), and Department of Diagnostic and Interventional Neuroradiology (B.B., T.N.), Eberhard Karls-University Tübingen; German Research Center for Neurodegenerative Diseases (K.N.K., S.B., R.S., R.K., L.S.), Tübingen; and CeGaT GmbH (S.B.), Center for Genomics and Transcriptomics, Tübingen, Germany.

Neurology
|November 8, 2013
PubMed
Summary

Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) is linked to CSF1R gene mutations. The study found de novo mutations and reduced penetrance, impacting genetic counseling for at-risk individuals.